BUZZ-Lantern Pharma 因乳腺癌药物获得 FDA "快速通道 "标签而上涨

Reuters
03 Dec 2024

((自动化翻译由路透提供,请见免责声明 ))

12月3日 - ** 癌症药物开发商Lantern Pharma 的股价盘前上涨约15%至3.63美元

** LTRN称,美国食品和药物管理局已授予其治疗一种被称为三阴性乳腺癌的乳腺癌的实验性药物 "快速通道 " (link) (TNBC)

** 这种名为LP-184的药物在治疗TNBC方面显示出了临床前疗效 - LTRN

** FDA的 "快速通道 "地位加快了对治疗严重疾病的药物的审查速度

** 截至上次收盘,该公司股价已累计下跌 26.2

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10